[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma. - Wikidata - awgldk - TriplyDB

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

http://www.wikidata.org/entity/Q30442436

about

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients The role of functional imaging in the tumor patient Invited review--neuroimaging response assessment criteria for brain tumors in veterinary patients [Molecular imaging in neurological diseases].Improving contrast enhancement in magnetic resonance imaging using 5-aminolevulinic acid-induced protoporphyrin IX for high-grade gliomas.Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?The Sum of Tumour-to-Brain Ratios Improves the Accuracy of Diagnosing Gliomas Using 18F-FET PET Advances in neuro-oncology imaging.Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma.A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma.Amino acid PET and MR perfusion imaging in brain tumours.(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report Influence of blood-brain barrier permeability on O-(2-18F-fluoroethyl)-L-tyrosine uptake in rat gliomas.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Anaplastic astrocytoma.Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.Reproducibility of O-(2-(18)F-fluoroethyl)-L-tyrosine uptake kinetics in brain tumors and influence of corticoid therapy: an experimental study in rat gliomas.Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy.Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?PET imaging in glioma: is it time for mainstream practice?Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.Reply to "[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.Brain metastases: neuroimaging.MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Utilizing 18F-fluoroethyl-l-tyrosine positron emission tomography in high grade glioma for radiation treatment planning in patients with contraindications to MRI.Developmental Venous Anomalies Mimicking Neoplasm on 11C-Methionine PET and DSC Perfusion MRI.Copper-mediated aromatic radiofluorination revisited: efficient production of PET tracers on a preparative scale.The use of O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of gliomas located in the brainstem and spinal cord.Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications.Dynamic 18F-FET PET in suspected WHO grade II gliomas defines distinct biological subgroups with different clinical courses.

P2860

Q26853308-81238007-3660-4F45-8C30-30B70F321324 Q26998680-960B91AE-E1D4-4082-AA0B-5AF22E9959FC Q30692995-204BAE8E-D519-4C4A-A659-24683C3800CE Q31108303-60A8B3C7-1EB1-4B42-822E-5013358A4B99 Q33598949-A5A27938-35F2-4844-8FE2-DE97EEE40F4B Q33740196-5A747F6A-6924-4ECE-9316-E6C1A67F743A Q34348544-17A780B3-5159-4350-A53C-A3478DE4D33B Q35156126-4D319388-C61C-446C-8BBB-E44A38A1C88B Q35679377-C58B0F4C-DAA7-45DA-8A6D-565AF45E8F5E Q35807945-9BEEAE39-D137-44A7-B829-F9EAF8247265 Q36339461-27642B0C-4AA1-4384-85E3-C6EAC6103C06 Q36785136-7D883B3F-89D7-4719-81A5-73D8CA455BDA Q37000245-8ECD1BAB-BDF6-4B63-BDDE-5339C251D1B4 Q37614748-BC69D3CB-C5E7-4D54-A55F-075B6A19D2E9 Q37675804-7F725AA6-F6D0-4F66-BC83-D5CB50A1EF89 Q38403271-F2C81842-9F84-4E7A-B63C-F9D10A839B87 Q38640193-A1F4F43F-4133-4D32-8528-48B1083D9F74 Q38691946-87F26B74-2185-4A52-B047-8FED3B2BCFEE Q38720940-3A54FCBA-044C-4BA9-A876-2F41DA5DA7AD Q38747089-5778689D-8A11-47A6-B709-91A30348C933 Q38815396-9DFB2E65-CF30-4620-8D14-AD4670290598 Q38845657-CD9BA8E0-7B5C-422E-BA07-2A4AE705AB85 Q38964679-D197EABC-DADA-4861-9A10-43008EE91F4E Q39031636-5F79F488-0C50-47CD-B308-DC963C8001EE Q40232491-E3C3999B-37FA-4436-B262-45356D2868AD Q41994160-1EB71E58-15D8-439A-9C38-E0696353D283 Q42234940-7A04AEE4-E886-4254-9D28-23E022215A6E Q42332774-83345DEA-DC60-47B0-88DB-1AF7952CC4B4 Q43120586-6CA7E5B1-AE52-48E5-AD97-EBD74DEF4C21 Q43120590-DA02D258-FB26-4193-A165-14C156335557 Q47879878-04108325-5207-4613-8E17-0C2955305947 Q47973107-ED476F7D-ADD2-4DE0-BB99-40638C1A4CA0 Q48158155-29BC8B88-AD93-4D54-9B3D-12E1B7D5B6C3 Q48240734-D928C049-46D6-4A3D-83DD-75CDCB297926 Q48256280-AF4101CC-AAEE-4F3C-8474-73031EB4B8C8 Q48313658-53F15268-97D5-48AF-82FC-09ACA80D07B9 Q48376735-0C76635D-F5EE-4082-9338-8714FB5FF147 Q48912145-9DBB8F1B-A13F-48D6-BAC9-736EA817FAE5 Q55388033-1D07A65F-2693-4272-91B8-1923ABE45129 Q55460679-D3A0A643-7004-4816-B2AA-9BC8C4FA53DF

P2860

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.

http://www.wikidata.org/entity/Q30442436

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@ast

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@en

type

label

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@ast

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@en

prefLabel

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@ast

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@en

P1433

Q30442436-DAFFE466-42A3-440A-80CC-272DC254F570

P1476

Q30442436-8F875D3E-2752-41FD-ABC1-846DAD728305

P2093

Q30442436-0DC72056-018B-4310-AE4A-E30961558E3D

Q30442436-1C2838D6-F8D4-4F19-B5CA-B37ADF1222F2

Q30442436-3A88FC1B-3E58-4716-9571-9CBC8C70D9C8

Q30442436-4CC40C46-5669-4F5A-AADA-34B04B85C54E

Q30442436-586D418B-6B7F-4A84-AB69-BF3683E68BD1

Q30442436-58E97A54-E6F7-49B6-83CD-5B36D8950C6F

Q30442436-856D2A85-32CA-4078-AF4C-E1EF5CECFEE8

Q30442436-97A20C0B-FD6C-4031-97DF-52B54E16C654

Q30442436-9BB30158-FE8C-4238-A699-54E338ACB10A

Q30442436-A103BADA-FEEF-47A4-9D54-B9CBA30E51EE

P2860

Q30442436-03DF7702-B135-4399-88E3-614E830125BA

Q30442436-0BE6634A-4707-4FF7-AA6A-E0516FB3A96E

Q30442436-13FFE6D5-8F76-4608-8825-2F123337EBC3

Q30442436-1917D3BA-DDB0-4406-929D-D9FF0972A490

Q30442436-1C649A2F-D909-4755-B2AC-8CF52B97E6E0

Q30442436-1D9A6A13-4EE7-47AF-BE8F-FCB2A1906952

Q30442436-23152E1A-D8CF-441C-BC4B-F43023119742

Q30442436-3E9717AC-A759-442C-BA87-BB847A5B8A26

Q30442436-3F2F4BF4-4BDD-41F3-81E4-2E63CAB7C464

Q30442436-440FCBC2-35A4-465A-BDC8-6964EB66E81A

P304

Q30442436-D12448DA-C530-4C15-BDBB-8AC6AD8132F1

P31

Q30442436-3375DEEE-6A8B-46A6-8A86-CEE19E4A7DED

P356

Q30442436-3413DE02-286A-4F13-88A8-631C8D892D1F

P433

Q30442436-FAA51921-5710-467B-88B9-D3AFD4016EEB

P478

Q30442436-5CEFFF6F-C313-45A8-A0ED-036A507D4644

P50

Q30442436-1A31DC5F-A7B9-4803-9435-4EE71D5D9D76

Q30442436-91C61012-0DE1-43F9-9AD4-82FAF4569336

Q30442436-BF28B290-C633-4E00-B2F0-FB6F3D6C67BE

P577

Q30442436-58B32F20-31D3-4922-8CF3-3FDDBA36BF80

P5875

Q30442436-EAA616A1-62D7-4F59-8DF7-168CBD4EBF65

P698

Q30442436-93E8FC8E-D7A8-4140-8804-7D63370B5B14

P932

Q30442436-E317A9F3-A5F6-4762-9D1A-2919EF4FCAFA

P356

P1433

P1476

[18F]-fluoro-ethyl-L-tyrosine ...... t all that glitters is glioma.

@en

P2093

Andreas H Jacobs

http://www.w3.org/2001/XMLSchema#string

Christian la Fougère

http://www.w3.org/2001/XMLSchema#string

Daniel Putzer

http://www.w3.org/2001/XMLSchema#string

Georg Göbel

http://www.w3.org/2001/XMLSchema#string

Günther Stockhammer

http://www.w3.org/2001/XMLSchema#string

Irene J Virgolini

http://www.w3.org/2001/XMLSchema#string

Marcel Seiz

http://www.w3.org/2001/XMLSchema#string

Mark McCoy

http://www.w3.org/2001/XMLSchema#string

Markus Hutterer

http://www.w3.org/2001/XMLSchema#string

Michael Schocke

http://www.w3.org/2001/XMLSchema#string

P2860

Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.

The value of metabolic imaging in diagnosis and resection of cerebral gliomas.

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma.

Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis.

Radiolabeled amino acids: basic aspects and clinical applications in oncology.

Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomas.

Amino acid uptake in ischemically compromised brain tissue.

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.

PET for radiation treatment planning of brain tumours.

18F-FET-PET-based dose painting by numbers with protons.

P304

341-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOS300

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Martha Nowosielski

Christian la Fougère

P577

2013-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234703300

http://www.w3.org/2001/XMLSchema#string

P698

23335162

http://www.w3.org/2001/XMLSchema#string

P932

3578481

http://www.w3.org/2001/XMLSchema#string